NCT03223376 2025-12-01
FRUTIGA
Hutchmed
Phase 3 Completed
Clinical Trials
23 trialsNCT06941168 2025-04-23
Potential Advantages of Robotic Total Gastrectomy in Advanced Middle-Upper Gastric Cancer: A Multicenter Propensity Score Matching Analysis
Fujian Medical University
Completed
NCT02142322 2025-04-17
Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer
Seoul National University Hospital
Phase 2 Completed
NCT04195828 2025-04-01
Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer
Fujian Medical University
Phase 2 Completed
NCT06376773 2024-04-19
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.
Fujian Medical University
Completed
NCT02935634 2023-06-09
FRACTION-GC
Bristol-Myers Squibb
Phase 2 Completed
NCT00915382 2020-01-07
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
Phase 3 Completed
NCT00976768 2020-01-07
Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin
Asan Medical Center
Phase 2 Completed
NCT01049620 2020-01-07
RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX
Asan Medical Center
Phase 1 Completed
NCT01471470 2020-01-07
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
Asan Medical Center
Phase 2 Completed
NCT02451956 2019-12-30
Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy
Samsung Medical Center
Phase 2 Completed
NCT01503372 2019-02-12
PaFLO
Charite University, Berlin, Germany
Phase 2 Completed
NCT03350477 2019-01-25
Bioinformation Therapy for Gastric Cancer
Fuda Cancer Hospital, Guangzhou
Phase 2/3 Completed
NCT01472250 2017-05-09
A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China
Peking University
Completed
NCT01441336 2017-01-09
Laparoscopic Gastrectomy for Advanced Gastric Cancer
Seoul National University Bundang Hospital
Phase 2 Completed
NCT01152853 2015-11-20
PF299804-AGC
Seoul National University Hospital
Phase 2 Completed
NCT01136031 2015-05-20
TI-2ndAGC
Seoul National University Hospital
Phase 1/2 Completed
NCT00842491 2015-05-19
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer
Peking University
Phase 2 Completed
NCT02071043 2014-02-25
Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis
Shanghai Zhongshan Hospital
Phase 2 Completed
NCT01851941 2013-05-13
A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer
Seoul National University Hospital
Phase 2 Completed
NCT01238055 2013-04-09
Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer
Samsung Medical Center
Phase 2 Completed
NCT00821990 2012-01-20
Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer
Samsung Medical Center
Phase 3 Completed
NCT00743964 2010-01-15
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)
Samsung Medical Center
Phase 2 Completed